{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:22:30Z","timestamp":1782177750820,"version":"3.54.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1097\/01.gme.0000172271.78314.6d","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T09:20:35Z","timestamp":1126603235000},"page":"619-622","source":"Crossref","is-referenced-by-count":11,"title":["Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis"],"prefix":"10.1097","volume":"12","author":[{"given":"Maurizio","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Cagnacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco E","family":"Pansini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"de Aloysio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Sgarabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bacchi-Modena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210227","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.gme.0000102909.93629.8b","article-title":"Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of the North American Menopause Society.","volume":"10","year":"2003","journal-title":"Menopause"},{"key":"R2-20-20210227","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.maturitas.2004.03.003","article-title":"Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormone therapy.","volume":"48","author":"Skouby","year":"2004","journal-title":"Maturitas"},{"key":"R3-20-20210227","first-page":"27","article-title":"Position Statement by the Executive Committee of the International Menopause Society.","volume":"48","year":"2004","journal-title":"Maturitas"},{"key":"R4-20-20210227","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM198606193142505","article-title":"Biologic effects of transdermal estradiol.","volume":"314","author":"Chetkowski","year":"1986","journal-title":"N Engl J Med"},{"key":"R5-20-20210227","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 in postmenopausal women: oral versus percutaneous administration.","volume":"62","author":"De Ligniers","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20-20210227","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0140-6736(90)90605-5","article-title":"Transdermal administration of oestrogen\/progestagen hormone replacement therapy.","volume":"335","author":"Whitehead","year":"1990","journal-title":"Lancet"},{"key":"R7-20-20210227","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0378-5122(91)90237-K","article-title":"Neuroendocrine and clinical effects of transdermal 17 -estradiol in postmenopausal women.","volume":"13","author":"Cagnacci","year":"1991","journal-title":"Maturitas"},{"key":"R8-20-20210227","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.20463","article-title":"Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.","volume":"40","author":"Di Martino","year":"2004","journal-title":"Hepatology"},{"key":"R9-20-20210227","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.2.5406.426","article-title":"Hepatic impairment during the intake of contraceptive pills: clinical trial with postmenopausal women.","volume":"5406","author":"Eisalo","year":"1964","journal-title":"BMJ"},{"key":"R10-20-20210227","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.2.5410.688-c","article-title":"Oral contraceptives and liver damage.","volume":"5410","author":"Palva","year":"1964","journal-title":"BMJ"},{"key":"R11-20-20210227","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/bmj.2.5415.1011-b","article-title":"Oral contraceptives and liver damage.","volume":"5415","author":"Rice-Wray","year":"1964","journal-title":"BMJ"},{"key":"R12-20-20210227","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jama.1965.03090060012002","article-title":"Jaundice during treatment with oral contraceptive agents: report of two cases.","volume":"193","author":"Laarsson-Cohn","year":"1965","journal-title":"JAMA"},{"key":"R13-20-20210227","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(79)91454-5","article-title":"Hepatocellular carcinoma in a patient on oral contraception who had been exposed to hepatitis B virus.","volume":"28","author":"Oon","year":"1979","journal-title":"Lancet"},{"key":"R14-20-20210227","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0010-7824(82)90173-1","article-title":"Effects of oral contraception on liver function tests and serum proteins in women with past viral hepatitis.","volume":"26","author":"Shaaban","year":"1982","journal-title":"Contraception"},{"key":"R15-20-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004836-198404000-00009","article-title":"Severe and prolonged oral contraceptive jaundice.","volume":"6","author":"Lieberman","year":"1984","journal-title":"J Clin Gastroenterol"},{"key":"R16-20-20210227","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0676.2003.00811.x","article-title":"Impact of oestrogens on the progression of liver disease.","volume":"23","author":"Shimizu","year":"2003","journal-title":"Liver Int"},{"key":"R17-20-20210227","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1034\/j.1600-0676.2001.210507.x","article-title":"Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection.","volume":"21","author":"Shimizu","year":"2001","journal-title":"Liver"},{"key":"R18-20-20210227","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/gut.34.11.1639","article-title":"Hormone replacement therapy in chronic active hepatitis; a case report.","volume":"34","author":"Clements","year":"1993","journal-title":"Gut"},{"key":"R19-20-20210227","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2169\/internalmedicine.40.100","article-title":"Estrogen therapy in a male patient with chronic hepatitis C and irradiation-induced testicular dysfunction.","volume":"40","author":"Shimizu","year":"2001","journal-title":"Intern Med"},{"key":"R20-20-20210227","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3349\/ymj.2001.42.5.547","article-title":"Osteodystrophy in posthepatitic cirrhosis.","volume":"42","author":"Karan","year":"2001","journal-title":"Yonsei Med J"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200512050-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T04:36:05Z","timestamp":1618029365000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200512050-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.gme.0000172271.78314.6d","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}